Objectives. We determined hospitalization rates and disparities among people with HIV, which may have been underestimated in previous studies, as only those in medical care were included .
Hospitalization rates among people with human immunodeficiency virus (HIV) have fallen in recent years with the widespread use of highly active antiretroviral therapy. [1] [2] [3] [4] [5] [6] However, recent studies examining hospitalizations of people living with HIV in the United States have been limited to those in medical care, and it is unclear if results are generalizable to the total U.S. population with HIV. To produce more generalizable estimates, we conducted a cross-sectional analysis of hospitalization rates among people living with HIV using nationally representative data.
The outcome of hospitalization among people with HIV merits continued study. As antiretroviral therapy (ART) has been associated with a substantial reduction in hospitalization rates among people living with HIV, [1] [2] [3] [4] [5] [6] measuring population-based hospitalization rates may serve as a marker for access to and success of care on a population level. Changes in hospitalization rates may be more sensitive indicators of treatment failures or toxicity than changes in mortality. In addition, hospitalizations represent a substantial portion of the cost of HIV care, especially for those with advanced disease, 7 and decreases in hospitalizations may allow for the redistribution of resources to other aspects of HIV care.
Recent studies examining hospitalization rates among people living with HIV included only patients engaged in HIV care, possibly underestimating the true hospitalization rates. Population-based studies have estimated that approximately one-quarter of people with newly diagnosed HIV infection do not receive care within one year. [8] [9] [10] In addition, previous studies have shown that in any given year, up to one-half of people living with HIV are not in HIV care. 8, [11] [12] [13] Populations not in HIV care do not benefit from ART, and, therefore, may have significantly higher hospitalization rates, particularly for diseases associated with untreated HIV, such as opportunistic infections (OIs). Therefore, by only including those engaged in HIV care, cohort studies may underestimate true hospitalization rates.
Women and those in racial/ethnic minority groups are less likely to be engaged and retained in HIV care. 11, 14, 15 Therefore, previous studies may also have preferentially underestimated hospitalization rates in these groups by only including those engaged in care, thus underestimating gender and racial/ethnic disparities in hospitalization rates. To determine unbiased estimates of outcomes disparities by gender and race/ ethnicity, we aimed to estimate hospitalization rates for these groups while including patients not in care.
The goals of this study were to (1) estimate the nationwide rate of all-cause hospitalizations, hospitalizations for OIs, and in-hospital deaths among people living with HIV; and (2) determine if significant gender and racial/ethnic disparities exist in these outcomes for all people living with HIV in the U.S. We hypothesized that hospitalization rates among people living with HIV would be higher than has previously been reported, and that black people, Hispanic people, and women would have higher rates of overall hospitalization, more hospitalizations related to OIs, and a higher rate of in-hospital death.
MetHoDS

Study overview and outcomes
We used a cross-sectional design to estimate nationwide hospitalization rates among people living with HIV and to determine if there are disparities by gender and race/ethnicity. The primary outcome was hospitalization for any illness. Secondary outcomes included hospitalization with a diagnosis of any OI, hospitalization with a diagnosis of an OI preventable through the use of antibiotic prophylaxis (i.e., prophylaxis-preventable OI), and in-hospital death.
Data sources
We used two data sources for this study. We estimated the number of hospitalizations and in-hospital deaths among people living with HIV in the U.S. using the Nationwide Inpatient Sample (NIS), a part of the Healthcare Cost and Utilization Project, sponsored by the Agency for Healthcare Research and Quality. 16 We took the number of prevalent diagnosed HIV cases from estimates produced by the Centers for Disease Control and Prevention (CDC) using public health reporting data and mathematical modeling. 17
Number of hospitalizations
The NIS is a stratified survey sample of inpatient discharges in the U.S. In 2009, it consisted of data from 1,050 hospitals in 44 states weighted to allow calculation of national estimates. Discharge records in the NIS contain up to 15 International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes that correspond to discharge diagnoses. We included all discharges of people 13 years of age that contained an HIV diagnosis code (042 and V08) in this analysis. Previous research demonstrated the sensitivity of an 042 code for detecting a hospitalized person with HIV from the medical record to be 98%. 18 Data were extracted from the 2009 NIS using procedures to account for the complex weighted survey sample design. 19 Race was reported to the NIS in the form of either one race/ethnicity variable or two separate race and ethnicity variables. When reported as two separate variables, ethnicity took precedence over race (i.e., Hispanic people could be of any race). 20 The NIS samples hospitalizations without patient identifiers; therefore, it is not possible to determine whether the same person was hospitalized multiple times.
All OIs from the 1993 acquired immunodeficiency syndrome (AIDS) case definition 21 were linked to corresponding ICD-9 codes, as has been done previously. 18 26 If a hospitalization contained a code for both a prophylaxis-preventable OI and a non-prophylaxis-preventable OI, it was counted only once as prophylaxis-preventable. To determine the contribution of pregnancy, labor, and delivery to the overall hospitalization rate of females, hospitalizations were also searched for these diagnosis codes: 640-649, 650-659, 660-669, 670-677, 792.3, V22-V24, V27, and V28. If a hospitalization contained a code for pregnancy, labor, or delivery and a code for an OI, it was counted as both a pregnancy, labor, or delivery hospitalization and an OI hospitalization.
Calculation of hospitalization rates
We calculated hospitalization rates by dividing the number of hospitalizations of people living with HIV (the numerator) by the number of prevalent cases of HIV (the denominator). The number of prevalent HIV cases (the denominator) by gender and racial/ethnic group in the U.S. in 2009 was taken from CDC estimates. 17 CDC estimates report patients with diagnosed and undiagnosed HIV infection. Patients who were discharged from the hospital with undiagnosed HIV infection would not be found in our search of the NIS (the numerator), given that their status was unknown and, therefore, not coded in the medical record. Therefore, we used only estimates of prevalent diagnosed HIV cases as our denominator. In 2009, CDC estimated the number of prevalent diagnosed HIV cases to be 940,600 (95% confidence interval [CI] 908,237, 972,963).
We estimated the number of hospitalizations or in-hospital deaths (the numerator) using the NIS, as described previously. We performed separate calculations for overall hospitalizations, hospitalizations for OIs, hospitalizations for prophylaxis-preventable OIs, in-hospital deaths, and each gender and racial/ethnic group. To generate a 95% CI around the rate, we performed propagation of the standard error (SE) of both the NIS and CDC estimates.
Missing data
Variables of interest were missing for ,2% of hospitalizations in the NIS except for race, which was missing in 9.0% of hospitalizations, primarily because four states censor this variable. To allow inclusion of all data and to incorporate uncertainty around missing data, we performed a multistage multiple imputation procedure for all missing variables using methods suitable for large survey samples. [27] [28] [29] [30] [31] We included all variables in our imputation model that might predict missing information, including state-and county-level racial/ethnic proportions, 32 state racial/ethnic proportions of prevalent AIDS cases from public health reporting data, 33 hospital characteristics (e.g., bed size, rural/urban location, census region, and teaching status), discharge-level characteristics (e.g., age, race, primary expected payer, whether the admission was elective, length of stay, and total charges), and characteristics of the survey sample design itself, including sampling stratum and discharge weight. 27, 34 Five imputations were performed. Hospitalizations of people categorized as Asian or Native American, and those recorded in the NIS as being of other race, were combined into one category for imputation and analysis of demographic variables. Estimation of hospitalization rates was then limited to the racial/ethnic categories white, black, and Hispanic due to the low numbers of individuals and, therefore, high SEs of estimates among people classified as Asian, Native American, or other. The estimated number of hospitalizations (i.e., the national numerator) was found using the SAS ® PROC SURVEYFREQ procedure for each of the five imputed datasets by gender and race/ethnicity, and then those results were combined using SAS PROC MIANALYZE to produce a final estimate. 35 
Statistical analysis
First, we examined the characteristics of hospitalizations among people living with HIV; continuous variables are reported as means SEs, and dichotomous variables are reported as number (percent) with 95% CI. Next, to compare all-cause hospitalization rates, hospitalization rates with OIs, and in-hospital deaths by gender and race/ethnicity, we used the two-sample Z-test. We considered p0.05 to be statistically significant. We did not adjust p-values for multiple comparisons, as the risk of type I error was deemed acceptable a priori given the exploratory nature of this work.
We performed all statistical calculations using SAS version 9.2. 35 
Population-based hospitalization rate
Hospitalization rates by gender and race/ethnicity are presented in Figure 1 . 
DiScuSSion
In this study using nationally representative data, we found hospitalization rates among people living with HIV to be higher than rates that have previously been reported. In addition, we found that females are at significantly higher risk of hospitalization than males, and that black people are at significantly higher risk of hospitalization than white people. The increased risk for females and black people was seen in all hospitalizations, hospitalizations for OIs, and in-hospital mortality. Because our analysis included all people living with HIV rather than just those engaged in HIV care, we were able to report estimates of hospitalization rates and disparities unbiased by differential rates of medical care. Our findings suggest that, despite recent efforts to reduce disparities in HIV care, women have worse HIV outcomes than men, and black people have worse HIV outcomes than white people in the U.S. Despite increasingly advanced treatments, people living with HIV in the U.S. are hospitalized at high rates and high cost. Compared with three other recent HIV cohorts (Figure 2) , the rate estimated from our data (26.6 per 100 people) is 2.6 and 2.4 times that Excluding all hospitalizations with a diagnosis code for pregnancy, labor, or delivery, the hospitalization rate for females was 32 .8 per 100 population (95% CI 26 .9, 38 .8); this rate remained significantly higher than the rate for males (p50 .01) .
HIV 5 human immunodeficiency virus CI 5 confidence interval p=0.23 a of two other studies, 3, 37 and comparable with a third study. 38 Study cohorts were heterogeneous, and the two studies with lower hospitalization rates had more white people, more males, and more privately insured people than the remaining cohort study, as well as the current study. Additionally, the higher hospitalization rate we found may be due to our cross-sectional design using hospital discharge data, which allowed inclusion of people not engaged in HIV care.
Racial/ethnic and gender disparities in hospitalization rates likely arise from multifactorial origins. Previous work has shown that women and those in racial/ ethnic minority groups are less likely to be linked to and retained in care; therefore, they are less likely to reap the benefits of ART. 11, 14, 15 Even when in care, women and those in racial/ethnic minority groups have been shown to be less often prescribed ART or prophylactic antibiotics when indicated. [39] [40] [41] [42] [43] [44] [45] [46] [47] However, several previous studies of cohorts with equal access to care or that adjust for factors such as adherence and stage of disease have not found outcomes disparities, suggesting that delays in diagnosis, access to treatment, and adherence to medication may mediate gender and racial/ethnic disparities. [48] [49] [50] [51] [52] [53] Further work is urgently needed to design and evaluate programs aimed at these potentially intervention-sensitive factors to improve HIV care and outcomes for all groups. Two of the stated goals of the National HIV/AIDS Strategy, released by the White House on July 13, 2010, include (1) increasing access to care and improving health outcomes for people living with HIV and (2) reducing HIV-related health disparities by improving access to prevention and care services for all Americans. 54
Limitations
This study was subject to several limitations. First, we may not have captured all hospitalizations of people living with HIV due to the diagnosis code not appearing in administrative data. As a result, our estimates of hospitalization rates were likely conservative. In addition, we could not estimate hospitalizations among people living with undiagnosed HIV infection. Second, data from the NIS are provided on a per-discharge basis, so it cannot be determined if higher hospitalization rates in a certain group reflect a small number of individuals being hospitalized frequently or a more generalized increase in hospitalizations across the group. Among a cohort of people with HIV, 63% of patients who were hospitalized in 2007 were hospitalized once, 19% were hospitalized twice, and 18% were hospitalized three or more times. 38 Third, adjusted analyses were not possible with our data given that only summary statistics are known about prevalent HIV cases. The differences between gender and racial/ethnic groups that would remain after adjusting for all variables, such as CD4 lymphocyte counts or duration of HIV diagnosis, could not be determined. Finally, determination of racial/ ethnic category was not standardized across hospitals, may not have been by self-report, and was imputed for 9.0% of discharges; as such, misclassification could have biased our estimation of disparities in either direction.
concluSionS
Despite reductions in hospitalization rates associated with widespread use of ART, people with HIV are still hospitalized at high rates, and substantial gender and racial/ethnic disparities persist. Previous work has shown that women and those in racial/ethnic minority groups are less likely to be engaged and retained in HIV care. 9, 11, 14, 15 This finding may explain, at least in part, disparities in hospitalization rates. Efforts to systematically remove barriers to care and to find, engage, and retain all people living with HIV in care are urgently needed to realize the full benefits of ART for all groups.
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